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Cancer worldwide continues to grow despite advances for diagnosis and its
treatment. Among all types of cancer, lung cancer still ranks on the top as the leading
cause of deaths due to cancer in humans, with more than 1.7 million deaths each
year worldwide [1]. Boswellic acids (BAs) are pentacyclic terpenoids isolated from
oleo gum resin of Boswellia serrata has shown promising antiproliferative and
anticancer effects but allied with poor water solubility and bioavailability constraints
[2]. Nanoparticles in the field of nanomedicine have been evolving as vital carriers by
offering different drug targeting approaches for the effective delivery of conventional
chemotherapeutic agents in cancer management [3]. This nanocarrier approach
protects active drug molecules from devastating effects of physiological fluids
ultimately leading to minimization of drug dosage, sustainable drug release and
enhanced cellular uptake with significant accumulation inside the cancerous tissues.
Currently, anticancer investigations have been focused on biodegradable polymeric
NPs because sustained release cross-linked polymeric NPs enable enhancement of
aqueous solubility due to nano-sized particles with significant bioavailability
improvements by protecting drugs from the gastrointestinal tract [4-5].
The main aim of the research was to formulate BAs loaded chitosan nanoparticles
followed by characterisation and evaluation of in vitro release. The developed
formulation was evaluated on human lung cancer cell line A549.
In the current study, we made an effort to fabricate the BAs loaded chitosan
nanoparticles using ionic gelation technique and explore their efficacy in vitro in
lung cancer cell line A549. The influence of independent variables, chitosan
concentration (X1), Sodium tripolyphosphate (NaTPP) volume (X2) and
tripolyphosphate concentration (X3) were studied and optimised on dependent
variables (particle size and entrapment efficiency) using central composite design.
The optimised formulation were observed spherical in shape with excellent
entrapment efficiency (80.06 ± 0.48), showed sustained release at pH 1.2 and
maximum release at pH 6.8. Drug encapsulation can be attributed to physical
entrapment or chemical conjugation. Polydispersity index (PDI) represents the size
distribution of and uniformity of nanoparticles. The positive reading of zeta potential
indicates that there is stable dispersion between particles which reduces the
chances of aggregation. The minimum particle size of 67.5 nm having PDI value
0.147 (confirming monodispersity) was observed in formulation CNP7 at a lower
value of chitosan concentration, a high value of NaTPP volume and high value of
NaTPP concentration. The cytotoxicity assay revealed enhanced cytotoxicity for
drug-loaded nanoparticles in contrast to the free drug having an IC50 value of
17.29 μM and 29.59 μM, respectively. Flow cytometry confirmed that treatment of
cells with 40 µg/ml had arrested 22.75 ± 0.3 % at SubG0 phase of the cell cycle
when compared to untreated A459 cells. The observed results justified the BAs
loaded chitosan nanoparticles were effective due to greater cellular uptake,
sustained intercellular drug retention and enhanced anti-proliferative effect by
inducing apoptosis.
BAs loaded chitosan nanoparticles were synthesised using ionic gelation technique.
The influence of independent variables were studied and optimised on dependent
variables using central composite design. The cytotoxic effects of free BAs and BAs
loaded CNPs on Human Lung cancer (A-549) cell lines was evaluated by MTT
assay. Optimum formulation obtained after statistical optimization was further
explored to find out cell death confirmation by apoptotic studies especially DNA
ladder assay and cell cycle analysis by Flow cytometry.
The study reveals that the BAs loaded chitosan nanoparticles prepared by using
ionic gelation technique stimulate apoptosis in A549 cell line, exhibiting its potent
cytotoxic activity. Nanoencapsulation process may also be assisting the entry of
BAs into the cancerous cells, providing targeted effects and better patient
compliance. Overall, our study highlighted the relevance of NPs of BAs in targeting
lung cancer as an alternative treatment over the existing chemotherapy, providing a
new direction to the cancer clinic. Furthermore, the findings can also be extended
to various other phytochemicals and types of cancer.
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3. Cytotoxic Studies
Cell cycle analysis
a) Control A-459 cells b) A-459 cells treated with 20 µg/mL of sample c) A-459 cells treated with 40 
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BAS CNPs 67.5±0.2 nm 0.147± 0.02 nm 77.6±0.6 nm 80.1±0.4
1. Experimental design
